The role of Epidermal Growth Factor Receptor Family in mammary tumorigenesis and metastasis
The role of Epidermal Growth Factor Receptor Family in mammary tumorigenesis and metastasis
批准号:
171470
负责人:
Muller William J
金额:
$56.48万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2008
资助国家:
加拿大
项目状态:
已结题
起止时间:
2008-09-01 至 2013-09-01
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Elevated expression of members of a class of growth factor receptors known as the epidermal growth factor receptor (EGFR) family have been implicated as important determinants the induction of breast cancer. The major focus of this renewal application is
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Identifying the molecular and environmental factors involved in promoting escape from breast cancer dormancy.
-
批准号:488246
-
项目类别:Operating Grants
-
资助金额:$83.04万
-
财政年份:2023
-
负责人:Muller William J
-
依托单位:
Chi3L1 (YKL-40) plays a multifaceted role in modulating tumor immune microenvironment during breast cancer progression.
-
批准号:478513
-
项目类别:Operating Grants
-
资助金额:$93.07万
-
财政年份:2023
-
负责人:Muller William J
-
依托单位:
Identifying the molecular and environmental factors involved in promoting escape from breast cancer dormancy.
-
批准号:483129
-
项目类别:Operating Grants
-
资助金额:$7.29万
-
财政年份:2023
-
负责人:Muller William J
-
依托单位:
Identification of Stat1 signaling pathway(s) involved in mediating tumor escape from immune surveillance.
-
批准号:490747
-
项目类别:Operating Grants
-
资助金额:$4.55万
-
财政年份:2023
-
负责人:Muller William J
-
依托单位:
The multifaceted role of c-Src tyrosine kinase in breast cancer progression.
-
批准号:468470
-
项目类别:Operating Grants
-
资助金额:$83.6万
-
财政年份:2022
-
负责人:Muller William J
-
依托单位:
Chi3L1 (YKL-40) plays a multifaceted role in modulating tumor immune microenvironment during breast cancer progression.
-
批准号:472379
-
项目类别:Operating Grants
-
资助金额:$7.29万
-
财政年份:2022
-
负责人:Muller William J
-
依托单位:
Role of epigenetic modulation in breast cancer etiology and drug resistance.
-
批准号:368101
-
项目类别:Operating Grants
-
资助金额:$43.71万
-
财政年份:2017
-
负责人:Muller William J
-
依托单位:
The role of an alternative ErbB2 splice isoform in lung and breast cancer progression.
-
批准号:341907
-
项目类别:Operating Grants
-
资助金额:$59.59万
-
财政年份:2016
-
负责人:Muller William J
-
依托单位:
Development of a pre-clinical mouse model of Estrogen receptor alpha positive breast cancer to investigate the clinical efficacy of Selective Estrogen Receptor Modulators (SERMs)
-
批准号:341905
-
项目类别:Operating Grants
-
资助金额:$59.59万
-
财政年份:2016
-
负责人:Muller William J
-
依托单位:
Oncogene-mediated signal transduction in transgenic mouse models of human breast cancer
-
批准号:333085
-
项目类别:Operating Grants
-
资助金额:$274.58万
-
财政年份:2015
-
负责人:Muller William J
-
依托单位:
Canada Research Chair Tier 1
-
批准号:341360
-
项目类别:
-
资助金额:$101.99万
-
财政年份:2015
-
负责人:Muller William J
-
依托单位:
Oncogene-mediated signal transduction in ErbB2 transgenic models of mammary tumour progression
-
批准号:280158
-
项目类别:Operating Grants
-
资助金额:$56.09万
-
财政年份:2013
-
负责人:Muller William J
-
依托单位:
Identification of PI-3K coupled signalling pathways involved in mammary tumour progression: Implication for resistance to targeted therapy.
-
批准号:291796
-
项目类别:Operating Grants
-
资助金额:$61.28万
-
财政年份:2013
-
负责人:Muller William J
-
依托单位:
Role of epigenetic modulation in breast cancer etiology and drug resistance
-
批准号:277365
-
项目类别:Operating Grants
-
资助金额:$54.64万
-
财政年份:2012
-
负责人:Muller William J
-
依托单位:
Integrin-mediated signal transduction in mammary tumourigenesis and metastasis
-
批准号:249551
-
项目类别:Operating Grants
-
资助金额:$7.29万
-
财政年份:2011
-
负责人:Muller William J
-
依托单位:
The role of ErbB2-14-3-3 sigma signaling axis in cancer and development
-
批准号:199253
-
项目类别:Operating Grants
-
资助金额:$56.71万
-
财政年份:2010
-
负责人:Muller William J
-
依托单位:
国内基金
海外基金
登录
查看更多内容
凉膈散抑制ErbB2介导的巨噬细胞重编程治疗急性呼吸窘迫综合征的作用机制研究
-
批准号:JCZRLH202600626
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
ErbB2通过Nrf2/xCT介导氧化应激-糖代谢失衡在药物难治性颞叶癫痫中的作用机制与干预研究
-
批准号:2026JJ60091
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:肖玲
-
依托单位:
转录因子SOX9通过LASP-1激活ErbB2/HIF-1α/SLC7A11信号轴抑制铁死亡和促进肺癌侵袭的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:石建光
-
依托单位:
ESM1通过ERBB2/FAK/SRC通路促进HSPB1转录抑制顺铂诱导卵巢癌铁死亡的机制研究
-
批准号:2025JJ50493
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:李昱堃
-
依托单位:
AdipoRon 调控脂肪外泌体介导的 HGF/ERBB2/IRF6 抑制结
直肠癌的作用机制研究
-
批准号:2024JJ9552
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:艾琼嘉
-
依托单位:
ErbB2信号通路数学建模及其在乳腺癌耐药中应用研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:杨青
-
依托单位:
ErbB2第16号外显子可变剪接调控及其促进乳腺癌进展的机制研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:张金瑞
-
依托单位:
DRG神经元ErbB2受体及其异源二聚体介导骨癌痛外周敏化及电针干预研究
-
批准号:82174510
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2021
-
负责人:梁宜
-
依托单位:
ERBB2/ERBB3功能异常诱导内皮细胞失稳态及其调控胆囊癌免疫逃逸的机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:58万元
-
批准年份:2021
-
负责人:向冬喜
-
依托单位:
ERBB2突变激活PABPC3增强糖酵解在胆囊癌发生发展中的作用及机制研究
-
批准号:82072682
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:刘厚宝
-
依托单位: